{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:20Z","timestamp":1791314360388,"version":"4.3.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024308","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T21:48:03Z","timestamp":1314913683000},"page":"e24308","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":95,"title":["Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide"],"prefix":"10.1371","volume":"6","author":[{"given":"Melvin M.","family":"Evers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Pepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C. T.","family":"van Deutekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A. M.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan T.","family":"den Dunnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan B.","family":"van Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willeke M. C.","family":"van Roon-Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/hmg\/9.6.909","article-title":"Fourteen and counting: unraveling trinucleotide repeat diseases.","volume":"9","author":"CJ Cummings","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/10.14.1441","article-title":"SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.","volume":"10","author":"K Nakamura","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1471-4159.2009.06302.x","article-title":"The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.","volume":"110","author":"PO Bauer","year":"2009","journal-title":"J Neurochem"},{"key":"ref4","first-page":"593","article-title":"Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.","volume":"57","author":"NG Ranen","year":"1995","journal-title":"Am J Hum Gen"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/6.5.775","article-title":"Reduced penetrance of the Huntington's disease mutation.","volume":"6","author":"SM Mcneil","year":"1997","journal-title":"Hum Mol Genet"},{"key":"ref6","first-page":"1118","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington disease.","volume":"53","author":"SE Andrew","year":"1993","journal-title":"Am J Hum Gen"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins.","volume":"24","author":"CC Huang","year":"1998","journal-title":"Somat Cell Molec Gen"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1073\/pnas.022628699","article-title":"Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.","volume":"99","author":"PJ Muchowski","year":"2002","journal-title":"P Natl Acad Sci USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00450-3","article-title":"Insoluble TATA-binding protein accumulation in Huntington's disease cortex.","volume":"109","author":"WMC Roon-Mom","year":"2002","journal-title":"Mol Brain Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.","volume":"97","author":"JS Steffan","year":"2000","journal-title":"P Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment.","volume":"10","author":"CA Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14734220510007914","article-title":"The wide spectrum of spinocerebellar ataxias (SCAs).","volume":"4","author":"MU Manto","year":"2005","journal-title":"Cerebellum"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.","volume":"3","author":"L Schols","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12311-008-0009-0","article-title":"Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.","volume":"7","author":"A Matilla-Duenas","year":"2008","journal-title":"Cerebellum"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","article-title":"Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice.","volume":"95","author":"IA Klement","year":"1998","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph Disease at chromosome 14Q32.1.","volume":"8","author":"Y Kawaguchi","year":"1994","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajmg.b.30088","article-title":"Identification of a novel 45 repeat unstable allele associated with a disease phenotype at the MJD1\/SCA3 locus.","volume":"133B","author":"QS Padiath","year":"2005","journal-title":"Am J Med Genet B"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12311-008-0013-4","article-title":"SCA3: Neurological features, pathogenesis and animal models.","volume":"7","author":"O Riess","year":"2008","journal-title":"Cerebellum"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00018-008-8403-9","article-title":"Atrophins' emerging roles in development and neurodegenerative disease.","volume":"66","author":"Y Shen","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1094-177","article-title":"Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA).","volume":"8","author":"S Nagafuchi","year":"1994","journal-title":"Nature Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.","volume":"125","author":"RK Graham","year":"2006","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pone.0000238","article-title":"Proteasome activator enhances survival of Huntington's disease neuronal model cells.","volume":"2","author":"H Seo","year":"2007","journal-title":"PLoS ONE"},{"key":"ref23","article-title":"Autophagy and misfolded proteins in neurodegeneration.","author":"DJ Metcalf","year":"2010"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tig.2009.11.005","article-title":"Therapeutic gene silencing strategies for polyglutamine disorders.","volume":"26","author":"J Scholefield","year":"2010","journal-title":"Trends Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/cgt.2009.53","article-title":"Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.","volume":"16","author":"DD Rao","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2007.07.039","article-title":"Antiviral immunity directed by small RNAs.","volume":"130","author":"SW Ding","year":"2007","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained Effects of Nonallele-Specific Huntingtin Silencing.","volume":"65","author":"V Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.","volume":"26","author":"I Dragatsis","year":"2000","journal-title":"Nat Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1242\/dmm.000653","article-title":"Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model.","volume":"2","author":"S Zhang","year":"2009","journal-title":"Dis Model Mech"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts.","volume":"19","author":"PHJ van Bilsen","year":"2008","journal-title":"Hum Gene Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molcel.2007.01.031","article-title":"Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets.","volume":"25","author":"J Krol","year":"2007","journal-title":"Mol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi.","volume":"105","author":"JL McBride","year":"2008","journal-title":"P Natl Acad Sci USA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"VI\/2","DOI":"10.1007\/PL00007785","article-title":"Genetics of amyotrophic lateral sclerosis.","volume":"247","author":"W Robberecht","year":"2000","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease.","volume":"116","author":"RA Smith","year":"2006","journal-title":"J Clin Invest"},{"key":"ref35","article-title":"Safety,tolerability,and activity study of ISIS SOD1Rx to treat familial Amyotrophic Lateral Sclerosis (ALS) caused by SOD1 gene mutations (SOD-1). NCT01041222","year":"2009"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.","volume":"49","author":"KT Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"ref37","first-page":"315","article-title":"Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.","volume":"392","author":"J Hu","year":"2011","journal-title":"Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.","volume":"27","author":"JX Hu","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2009.04975.x","article-title":"Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA.","volume":"1175","author":"JX Hu","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.","volume":"10","author":"Y Trottier","year":"1995","journal-title":"Nat Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","article-title":"Polyglutamine expansion as a pathological epitope in Huntington's disease and 4 dominant cerebellar ataxias.","volume":"378","author":"Y Trottier","year":"1995","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.0907112106","article-title":"Triplet repeat length bias and variation in the human transcriptome.","volume":"106","author":"M Molla","year":"2009","journal-title":"P Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue.","volume":"11","author":"S Zeitlin","year":"1995","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: new developments in Huntington's disease research.","volume":"24","author":"E Cattaneo","year":"2001","journal-title":"Trends Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: An alternative approach to Huntington's disease.","volume":"6","author":"E Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type Huntingtin protects from apoptosis upstream of caspase-3.","volume":"20","author":"D Rigamonti","year":"2000","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.","volume":"282","author":"S Sarkar","year":"2007","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.","volume":"101","author":"A Yamamoto","year":"2000","journal-title":"Cell"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease.","volume":"121","author":"DW Sah","year":"2011","journal-title":"J Clin Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","article-title":"Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.","volume":"18","author":"JM Warrick","year":"2005","journal-title":"Mol Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?","volume":"19","author":"S Alves","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination.","volume":"362","author":"I Schmitt","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e1001021","DOI":"10.1371\/journal.pgen.1001021","article-title":"Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.","volume":"6","author":"J Crespo-Barreto","year":"2010","journal-title":"PLoS Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1074\/jbc.M610274200","article-title":"Functional architecture of atrophins.","volume":"282","author":"Y Shen","year":"2007","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","article-title":"Allele-specific silencing of mutant Huntington's disease gene.","volume":"108","author":"Y Zhang","year":"2009","journal-title":"J Neurochem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.","volume":"217","author":"MS Lombardi","year":"2009","journal-title":"Exp Neurol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.","volume":"19","author":"EL Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1261\/rna.28106","article-title":"Off-target effects by siRNA can induce toxic phenotype.","volume":"12","author":"Y Fedorov","year":"2006","journal-title":"RNA"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways.","volume":"441","author":"D Grimm","year":"2006","journal-title":"Nature"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic Administration of PRO051 in Duchenne's muscular dystrophy.","volume":"364","author":"NM Goemans","year":"2011","journal-title":"New Engl J Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051.","volume":"357","author":"JC van Deutekom","year":"2007","journal-title":"New Engl J Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.","volume":"3","author":"MA Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.0905780106","article-title":"Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.","volume":"106","author":"SAM Mulders","year":"2009","journal-title":"P Natl Acad Sci USA"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","article-title":"Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.","volume":"39","author":"M de Mezer","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0960-8966(02)00086-X","article-title":"Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.","volume":"12","author":"A Aartsma-Rus","year":"2002","journal-title":"Neuromuscular Disord"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR.","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/gkp045","article-title":"Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data.","volume":"37","author":"JM Ruijter","year":"2009","journal-title":"Nucleic Acids Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:05:48Z","timestamp":1589029548000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024308"}},"subtitle":[],"editor":[{"given":"Joseph Charles","family":"Glorioso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024308","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}